Bio-Rad Laboratories has announced the worldwide launch of its D-10 Dual Program for comprehensive haemoglobin testing
The Dual Program runs on the company's automated D-10 haemoglobin testing system and features HbA1c and HbA2/F/A1c assays for diabetes monitoring and beta-thalassemia screening.
"This new state-of-the-art programme will enable mid-sized laboratories to upgrade their haemoglobinopathy testing services and meet new CAP (College of American Pathologists) guidelines for quantitative HbA2 beta-thalassemia testing," said John Goetz, vice president of clinical diagnostics.
Bio-Rad's compact, easy-to-use D-10 system is a fully automated hemoglobin testing instrument that provides fast switching between programmes without changing reagents or cartridges.
The new Dual Program assay provides simultaneous quantitative results for HbA2, HbF and HbA1c levels in whole blood samples in 6.5 minutes.
